Concepedia

R S McCormick

RS

Statistics

Publications

2

Citations

79

H-Index

2

Active since

2005

Affiliations

Seagen (United States)(Current)

R S McCormick is an author at Seagen (United States) specializing in cancer biology, oncology, and medicine.

Publications per year

2005–2011

2

Publications

2

Signaling via the anti-CD30 mAb SGN-30 sensitizes Hodgkin's disease cells to conventional chemotherapeutics

Charles G. Cerveny, C-L Law, R S McCormick et al. · Leukemia · 2005 · 62 citations

, , +4

Proapoptotic signaling activity of the anti-CD40 monoclonal antibody dacetuzumab circumvents multiple oncogenic transformation events and chemosensitizes NHL cells

Timothy S. Lewis, R S McCormick, Ivan J. Stone et al. · Leukemia · 2011 · 17 citations

, , +12

1–2 of 2